Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
06/2010
06/01/2010US7727550 Biologically active native biomatrix composition
06/01/2010US7727538 Methods and compounds for the treatment of mucus hypersecretion
06/01/2010US7727536 EG-VEGF nucleic acids and polypeptides and methods of use
06/01/2010US7727535 Protein comprising amino acid sequence with one to 20 amino acid substitutions, deletions or insertions; lower affinity binding to alpha thrombin, lower aggregation, or proteolysis resistance; inflammation, thrombosis, atherosclerosis, angioplasty-related restenosis; cardiovascular disorders
06/01/2010US7727533 Serpentine transmembrane antigens expressed in human cancers and uses thereof
06/01/2010US7727519 Method for treating hepatitis C virus with omega interferon
06/01/2010US7727518 Method of using IL-29 cysteine mutant to treat hepatitis C and hepatitis B
06/01/2010CA2442679C Methods for secretory production of proteins
06/01/2010CA2441952C Plasmodium falciparum ama-1 protein and uses thereof
06/01/2010CA2424700C Genetic immunisation against cervical carcinoma
06/01/2010CA2393476C Dna sequence imparting cytoplasmic male sterility, mitochondrial genome, nuclear genome, mitochondria and plant containing said sequence and process for the preparation of hybrids
06/01/2010CA2358915C Modified hiv env polypeptides
06/01/2010CA2353816C Compositions and methods for enhancement of major histocompatibility complex class i restricted antigen presentation
06/01/2010CA2352231C Stable, attenuated rabies virus mutants and live vaccines thereof
06/01/2010CA2336221C Human neuronal acid-sensitive cationic channels, its cloning and applications
06/01/2010CA2332627C Porcine circovirus and parvovirus vaccine
06/01/2010CA2304376C Dna-construct for the tissue-specific expression of a blood coagulation factor
06/01/2010CA2291851C Stabilized antithrombin iii preparation
06/01/2010CA2288373C Human cerberus protein
06/01/2010CA2221495C Methods and uses for apoptin
06/01/2010CA2219961C Vasopermeability enhancing peptide of human interleukin-2 and immunoconjugates thereof
06/01/2010CA2160800C Ctp modified gonadotropic proteins
06/01/2010CA2115839C Hla-restricted hepatitis b virus ctl epitopes
05/2010
05/27/2010WO2010060096A2 Compositions and methods for increasing cellulose production
05/27/2010WO2010060095A1 Bispecific egfr/igfir binding molecules
05/27/2010WO2010059984A1 Il-29 mutants and uses thereof
05/27/2010WO2010059958A2 Artificial lectin mimics and uses thereof
05/27/2010WO2010059899A2 Vaccine for runting-stunting syndrome
05/27/2010WO2010059785A1 Cloning, expression and purication of recombinant porcine intrinsic factor for use in diagnostic assay
05/27/2010WO2010059626A1 Filamentous fungi with impaired ptrb activity for altered protein production
05/27/2010WO2010059315A1 Human serum albumin linkers and conjugates thereof
05/27/2010WO2010058428A2 Identification of genes related to abiotic stress tolerance in jatropha curcas
05/27/2010WO2010058419A1 Tumor necrosis factor alpha inhibiting peptides and uses thereof
05/27/2010WO2010058396A1 A cd44vra antibody and diagnostic and therapeutic methods using same
05/27/2010WO2010058238A1 Lantibiotic carboxyamide derivatives with enhanced antibacterial activity
05/27/2010WO2010058100A1 Mutant proteins of the f protein of piv-5 and piv-2
05/27/2010WO2010058099A1 Mutant proteins of the f protein of piv-5 and piv-2
05/27/2010WO2010058097A1 Truncated cd20 protein, deltacd20
05/27/2010WO2010058023A1 High affinity t cell receptor and use thereof
05/27/2010WO2010057985A2 Salmonella marker vaccine
05/27/2010WO2010057961A1 Peptide synthesis using enzymatic activation and coupling
05/27/2010WO2010057946A1 Composition comprising a hydrophobin for gluing paper products
05/27/2010WO2010057882A2 Composition for producing anti-amyloid beta peptide antibodies with d-peptides
05/27/2010WO2010057620A1 Expression cassettes for seed-enhanced expression in plants
05/27/2010WO2010057330A1 Recombinant peptide molecule for treating saprolegniasis
05/27/2010WO2010057259A1 Protein stability assay using a fluorescent reporter of protein folding
05/27/2010WO2010057251A1 Peptide conjugates for suppressing an immune response, methods of making and uses therefor
05/27/2010WO2010041145A3 Il-17-mediated transfection methods
05/27/2010WO2010039748A3 Botulinum neurotoxin e receptors and uses thereof
05/27/2010WO2010038145A3 Kit for the optimisation of protein synthesis/secretion
05/27/2010WO2010033753A3 Mutant delta5 desaturases and their use in making polyunsaturated fatty acids
05/27/2010WO2010029311A3 Herbicide tolerant plants
05/27/2010WO2010026473A3 Pta072 protein
05/27/2010WO2010019262A3 Polyvalent vaccine
05/27/2010WO2010014830A3 Peptide therapeutics that bind vegf and methods of use thereof
05/27/2010WO2010001409A3 Vaccine composition useful for hpv and hepatitis b infections and a method for preparing the same
05/27/2010WO2009155504A3 Methods for the modulation of angiogenesis
05/27/2010WO2009131698A3 PHOSPHORYLATED RECOMBINANT N-ACETYL-alpha-D- GLUCOSAMINIDASE (NaGlu) AND USES THEREOF
05/27/2010WO2003031572A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
05/27/2010WO1990007321A3 Lymphocyte receptor homing sequences and their uses
05/27/2010US20100132071 Plants Having Enhanced Yield-Related Traits And A Method For Making The Same
05/27/2010US20100132062 Rice Mutant Allele
05/27/2010US20100132056 Germ Cell Marker Using Fish Vasa Gene
05/27/2010US20100131258 Method for identifying protein synthesis inhibitors by ribosome structure
05/27/2010US20100130730 Protein formulations for use at elevated temperatures
05/27/2010US20100130729 Mu-1, member of the cytokine receptor family
05/27/2010US20100130728 Taci-immunoglobulin fusion proteins
05/27/2010US20100130726 Methods for reducing the mitogenicity of lectin compositions
05/27/2010US20100130725 Methods for characterizing molecules
05/27/2010US20100130724 Mammalian cytokines; related reagents and methods
05/27/2010US20100130720 Artificial binding proteins based on a modified alpha helical region of ubiquitin
05/27/2010US20100130684 Polymer factor ix moiety conjugates
05/27/2010US20100130590 Deletion bearing bard1 isoforms and use thereof
05/27/2010US20100130585 Methods and compositions for investigation and treatment of cancer using a g-protein coupled eicosanoid receptor
05/27/2010US20100130430 Stabilized therapeutic small helical antiviral peptides
05/27/2010US20100130424 Crhr2 peptide agonists and uses thereof
05/27/2010US20100130420 Novel chimeric ligand-gated ion channels and methods of use thereof
05/27/2010US20100130419 Artery- and Vein-Specific Proteins and Uses Therefor
05/27/2010US20100130417 Transforming growth factor alpha hii
05/27/2010US20100130416 Modulation of angiogenesis by a-beta peptide fragments
05/27/2010US20100130414 Methods of Using E2F2 for the Treatment of Hypertension
05/27/2010US20100130411 Method for treating cartilage disorders
05/27/2010US20100130410 Neural regeneration peptides and methods for their use
05/27/2010US20100129927 Peptides for Use in Diagnosing the Presence of Ruptured Atherosclerotic Lesions in a Individual
05/27/2010US20100129918 Compositions and methods for monitoring breast cancer treatment
05/27/2010US20100129905 Mammalian cytokines; related reagents and methods
05/27/2010US20100129901 Hepatitis c virus vaccine
05/27/2010US20100129869 Methods and compositions for inactivating glutamine synthetase gene expression
05/27/2010US20100129866 Method for production of dipeptide
05/27/2010US20100129864 Novel Bacteriocins, Transport and Vector System and Method of Use Thereof
05/27/2010US20100129842 Isobarically labeled analytes and fragment ions derived therefrom
05/27/2010US20100129826 Double stranded RNA receptor (dsRNA-R) and methods relating thereto
05/27/2010US20100129824 Distinguishing pca3 messenger rna species in benign and malignant prostate tissues
05/27/2010US20100129806 Regulation of cell survival by hsp90 and ip6k2
05/27/2010US20100129791 cDNA Encoding a Gene Bog (B5T Over-Expressed Gene) and its Protein Product
05/27/2010US20100129491 Tryptophan transporter gene and use thereof
05/27/2010US20100129405 Isolation, cloning and characterization of new adeno-associated virus (aav) serotypes
05/27/2010US20100129395 Hapten-carrier conjugates and uses thereof
05/27/2010US20100129391 Immunogenic compositions comprising mycobacterium tuberculosis polypeptides and fusions thereof
05/27/2010US20100129388 Protective proteins of s. agalactiae, combinations thereof and methods of using the same